oncology

Stanford Medicine researchers and colleagues found a way to make natural killer cells better at attacking cancer. In mice, the enhanced cells entered solid tumors and slowed their growth. One of the biggest successes of modern cancer treatment has been learning how to turn the immune system into a weapon. But that strategy has worked [...]

The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the drug’s second full approval after a 2023 clearance for IgA nephropathy. Travere’s stock rose 43 percent the next day, closing at $43.81.  The DUPLEX Data Behind a Second Approval FSGS damages the kidney’s filtering […]

A simple yeast-based food supplement may help restore the immune system’s ability to fight cancer, according to new research in mice. Scientists found that yeast beta-glucan reprogrammed early immune cells in the bone marrow, leading to stronger, longer-lasting cancer-fighting responses against colorectal, skin, and breast cancer cells.

Pancreatic cancer patients with at least 21 natural teeth survived nearly two years longer after surgery than those with fewer teeth in a study of 339 people. Researchers suspect tooth loss may reflect decades of inflammation, frailty, nutrition, and other factors tied to the body’s overall resilience.

Nature Communications, Published online: 22 August 2026; doi:10.1038/s41467-026-76959-6 Responses to immune checkpoint inhibitors (ICI) in esophageal squamous cell carcinoma (ESCC) are highly heterogeneous, and the mechanisms underlying therapeutic sensitivity remain incompletely understood. Here the authors present multi-omics profiling of ESCC patients receiving neoadjuvant therapy and identify…

A two-headed molecule designed by Stanford Medicine researchers hijacks one of the most common protein drivers of B-cell lymphoma, flipping it from its role as a promoter of cell growth into an arbiter of cell death.

Cancer drugs are often designed to block specific molecular targets, but what happens after they enter a cell is not always well understood. A new study published in Biophotonics Discovery demonstrates how advanced imaging technology can help answer that question. Using super-resolution microscopy, researchers tracked the cancer drug sunitinib inside living cells and observed how […]

The positive Phase 3 result therefore provides clinical validation, at the level of RFS and DMFS, of a strategy combining individualized neoantigen-directed immunotherapy with established PD-1 blockade. It is important, however, not to extend the current findings beyond what the trial has demonstrated. INTerpath-001 establishes efficacy endpoints in resected high-risk cutaneous melanoma. It does …

The University of Texas MD Anderson Cancer Center recognized outstanding faculty members for their exceptional contributions to cancer research, patient care, prevention, education and leadership during the Faculty Excellence Awards on August 20, 2026. The institution's annual Celebration of Faculty Excellence honors faculty whose achievements advance UT MD Anderson's mission to end cancer and ma…